This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, Y. Articles by Wu, D. Search for Related Content PubMed PubMed Citation Articles by Zhang, Y. Articles by Wu, D.

The LRP5 High-Bone-Mass G171V Mutation Disrupts LRP5 Interaction with Mesd

Department of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, Connecticut,¹ Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China,² Department of Structure Biology, St Jude Hospital, Memphis, Tennessee³

Received 8 January 2004/ Accepted 24 February 2004

The mechanism by which the high-bone-mass (HBM) mutation (G171V) of the Wnt coreceptor LRP5 regulates canonical Wnt signaling was investigated. The mutation was previously shown to reduce DKK1-mediated antagonism, suggesting that the first YWTD repeat domain where G171 is located may be responsible for DKK-mediated antagonism. However, we found that the third YWTD repeat, but not the first repeat domain, is required for DKK1-mediated antagonism. Instead, we found that the G171V mutation disrupted the interaction of LRP5 with Mesd, a chaperone protein for LRP5/6 that is required for transport of the coreceptors to cell surfaces, resulting in fewer LRP5 molecules on the cell surface. Although the reduction in the number of cell surface LRP5 molecules led to a reduction in Wnt signaling in a paracrine paradigm, the mutation did not appear to affect the activity of coexpressed Wnt in an autocrine paradigm. Together with the observation that osteoblast cells produce autocrine canonical Wnt, Wnt7b, and that osteocytes produce paracrine DKK1, we think that the G171V mutation may cause an increase in Wnt activity in osteoblasts by reducing the number of targets for paracrine DKK1 to antagonize without affecting the activity of autocrine Wnt.

This article has been cited by other articles:

• Balemans, W., Van Hul, W. (2007). The Genetics of Low-Density Lipoprotein Receptor-Related Protein 5 in Bone: A Story of Extremes. Endocrinology 148: 2622-2629 [Abstract] [Full Text]  
• Wei, Q., Yokota, C., Semenov, M. V., Doble, B., Woodgett, J., He, X. (2007). R-spondin1 Is a High Affinity Ligand for LRP6 and Induces LRP6 Phosphorylation and beta-Catenin Signaling. J. Biol. Chem. 282: 15903-15911 [Abstract] [Full Text]  
• Kang, S., Bennett, C. N., Gerin, I., Rapp, L. A., Hankenson, K. D., MacDougald, O. A. (2007). Wnt Signaling Stimulates Osteoblastogenesis of Mesenchymal Precursors by Suppressing CCAAT/Enhancer-binding Protein {alpha} and Peroxisome Proliferator-activated Receptor {gamma}. J. Biol. Chem. 282: 14515-14524 [Abstract] [Full Text]  
• Semenov, M. V., He, X. (2006). LRP5 Mutations Linked to High Bone Mass Diseases Cause Reduced LRP5 Binding and Inhibition by SOST. J. Biol. Chem. 281: 38276-38284 [Abstract] [Full Text]  
• Christodoulides, C., Laudes, M., Cawthorn, W. P., Schinner, S., Soos, M., O'Rahilly, S., Sethi, J. K., Vidal-Puig, A. (2006). The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis. J. Cell Sci. 119: 2613-2620 [Abstract] [Full Text]  
• van Bezooijen, R. L., Papapoulos, S. E., Hamdy, N. A., ten Dijke, P., Lowik, C. W. (2005). Control of Bone Formation by Osteocytes? Lessons from the Rare Skeletal Disorders Sclerosteosis and van Buchem Disease. IBMS BoneKEy 2: 33-38 [Full Text]  
• Li, Y., Chen, J., Lu, W., McCormick, L. M., Wang, J., Bu, G. (2005). Mesd binds to mature LDL-receptor-related protein-6 and antagonizes ligand binding. J. Cell Sci. 118: 5305-5314 [Abstract] [Full Text]  
• Henriksen, K., Gram, J., Hoegh-Andersen, P., Jemtland, R., Ueland, T., Dziegiel, M. H., Schaller, S., Bollerslev, J., Karsdal, M. A. (2005). Osteoclasts from Patients with Autosomal Dominant Osteopetrosis Type I Caused by a T253I Mutation in Low-Density Lipoprotein Receptor-Related Protein 5 Are Normal in Vitro, but Have Decreased Resorption Capacity in Vivo. Am. J. Pathol. 167: 1341-1348 [Abstract] [Full Text]  
• Carter, M., Chen, X., Slowinska, B., Minnerath, S., Glickstein, S., Shi, L., Campagne, F., Weinstein, H., Ross, M. E. (2005). Crooked tail (Cd) model of human folate-responsive neural tube defects is mutated in Wnt coreceptor lipoprotein receptor-related protein 6. Proc. Natl. Acad. Sci. USA 102: 12843-12848 [Abstract] [Full Text]  
• Semenov, M., Tamai, K., He, X. (2005). SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling Inhibitor. J. Biol. Chem. 280: 26770-26775 [Abstract] [Full Text]  
• Ai, M., Holmen, S. L., Van Hul, W., Williams, B. O., Warman, M. L. (2005). Reduced Affinity to and Inhibition by DKK1 Form a Common Mechanism by Which High Bone Mass-Associated Missense Mutations in LRP5 Affect Canonical Wnt Signaling. Mol. Cell. Biol. 25: 4946-4955 [Abstract] [Full Text]  
• Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., Wu, D. (2005). Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling. J. Biol. Chem. 280: 19883-19887 [Abstract] [Full Text]  
• Oyajobi, B. O., Shipman, C. M., Mundy, G. R. (2005). Recent Insights into Myeloma Bone Disease. IBMS BoneKEy 2: 17-25 [Full Text]  
• Hu, H., Hilton, M. J., Tu, X., Yu, K., Ornitz, D. M., Long, F. (2005). Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132: 49-60 [Abstract] [Full Text]